Antimalarial Medicines in Kenya. Availability, Quality and Registration Status. A Baseline Study Undertaken Prior to Nationwide Distribution of Artemether-Lumefantine (AL) in Kenya
(2007; 41 pages)


To provide regulatory support to the malaria treatment policy in Kenya, a baseline study of antimalarial medicines was undertaken in May 2006, immediately following introduction of the new malaria treatment guidelines, and prior to nationwide distribution and deployment of artemisinin combination therapies in the country. The survey aimed to provide baseline information to guide implementation of the MOH malaria treatment policy and to identify strategic issues for strengthening the national medicines regulatory system. The results and recommendations would guide the MOH, health sector development and implementing partners in making appropriate inputs and policy interventions to ensure availability of safe, efficacious and quality medicines in the country...

El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019